Michael Mulkerrin
Chief Tech/Sci/R&D Officer bei ADC THERAPEUTICS SA
Vermögen: 397 531 $ am 31.03.2024
Profil
Michael Mulkerrin is currently the Chairman-Biologics & Biotechnology Expert at The United States Pharmacopeia and the Chief Technical Operations Officer at ADC Therapeutics SA. He previously worked as a Senior Director-Process Sciences at Amgen, Inc., Interim Director at Abgenix, Inc., Principal at Genentech, Inc., Vice President-Process Development & Manufacturing at OncoMed Pharmaceuticals, Inc., and Head-Chemistry Manufacturing & Control Division at ADC Therapeutics SA. Mulkerrin holds a doctorate from the University of Georgia and an undergraduate degree from the University of Massachusetts.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ADC THERAPEUTICS LTD
0,11% | 01.02.2023 | 88 537 ( 0,11% ) | 397 531 $ | 31.03.2024 |
Aktive Positionen von Michael Mulkerrin
| Unternehmen | Position | Beginn |
|---|---|---|
| ADC THERAPEUTICS SA | Chief Tech/Sci/R&D Officer | 01.11.2022 |
The United States Pharmacopeia
 The United States Pharmacopeia Pharmaceuticals: MajorHealth Technology The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD. | Corporate Officer/Principal | 01.01.2010 |
Ehemalige bekannte Positionen von Michael Mulkerrin
| Unternehmen | Position | Ende |
|---|---|---|
| ADC THERAPEUTICS SA | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Director/Board Member | - |
| ONCOMED PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Ausbildung von Michael Mulkerrin
| University of Georgia | Doctorate Degree |
| University of Massachusetts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| ADC THERAPEUTICS SA | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
The United States Pharmacopeia
The United States Pharmacopeia Pharmaceuticals: MajorHealth Technology The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD. | Health Technology |
